Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Research Medical

This article was originally published in The Gray Sheet

Executive Summary

Research Medical: Plans to unveil its disposable beating heart minimally invasive cardiac surgery product line at the February 1997 Society of Thoracic Surgeons Meeting in San Deigo. The line includes the Anastaflo intravascular shunt for insertion into both ends of the severed coronary artery to prevent excess blood loss and the Visuflo humidified air blower with light source for lighting and removal of unwanted blood, both of which have been cleared by FDA. In addition, a "heart elevator" to minimize movement during bypass, a "stabilizing suction wand" to immobilize the section of heart operated on, and a femoral-to-arterial shunt to provide femoral artery blood flow to regions below the grafting site are expected to be 510(k) cleared in early 1997. The Midvale, Utah-based firm says Anastaflo and Visuflo will be commercially available by the end of the current quarter, with the other three devices expected to reach the market in June 1997...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel